Triplex forming oligonucleotides: Sequence-specific tools for gene targeting

Human Molecular Genetics

Volumn 10, Issue 20, 2001, Pages 2243-2251

  Knauert, M P ^a   Glazer, P M ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINOPURINE; 5 METHYLDEOXYCYTIDINE; 8 HYDROXYDEOXYGUANOSINE; 8 HYDROXYGUANINE; ADENINE; BINDING PROTEIN; COMPLEMENTARY DNA; CYTOSINE; DEOXYADENOSINE DERIVATIVE; DNA BASE; DNA FRAGMENT; DOUBLE STRANDED DNA; GUANINE; HOMING RECEPTOR; OLIGONUCLEOTIDE; PEPTIDE NUCLEIC ACID; POLYAMIDE; PURINE DERIVATIVE; PURINE NUCLEOTIDE; PYRIMIDINE DERIVATIVE; PYRIMIDINE NUCLEOTIDE; RNA; RNA DERIVATIVE; SUGAR; THIOGUANINE DERIVATIVE; THYMIDINE; THYMINE; TRIPLEX FORMING OLIGONUCLEOTIDE; UNCLASSIFIED DRUG; UNINDEXED DRUG; XANTHINE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; BINDING AFFINITY; CELL SPECIFICITY; CONTROLLED STUDY; DNA MODIFICATION; DNA STRUCTURE; DRUG DNA BINDING; DRUG EFFICACY; DRUG SPECIFICITY; DRUG STRUCTURE; GENE EXPRESSION REGULATION; GENE SEQUENCE; GENE TARGETING; GENE TECHNOLOGY; GENE THERAPY; GENETIC ANALYSIS; GENETIC MANIPULATION; GENETIC PROCEDURES; HUMAN; HUMAN CELL; IN VIVO STUDY; KNOCKOUT MOUSE; MAMMAL CELL; MOLECULAR GENETICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEQUENCE ANALYSIS; STRUCTURE ANALYSIS;

ANIMALIA; MAMMALIA;

EID: 0035475787     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/10.20.2243     Document Type: Review

References (100)

1. Formation of a three-stranded polynucleotide molecule
2. Specificity of the three-stranded complex formation between double-stranded DNA and single-stranded RNA containing repeating nucleotide sequences
3. Specificity in formation of triple-stranded nucleic acid helical complexes: Studies with agarose-linked polyribonucleotide affinity columns
4. A triple helix-forming oligonucleotide-intercalator conjugate acts as a transcriptional repressor via inhibition of NF κ B binding to interleukin-2 receptor α-regulatory sequence
5. Inhibition of DNA binding proteins by oligonucleotide-directed triple helix formation
6. Triplex formation by the human Ha-ras promoter inhibits Sp1 binding and in vitro transcription
7. Inhibition of transcription factor binding to the HER2 promoter by triplex-forming oligodeoxyribonucleotides
8. Specific inhibition of transcription by triple helix-forming oligonucleotides
9. Inhibition of in vitro transcription by a triplex-forming oligonucleotide targeted to human c-myc P2 promoter
10. Antiparallel polypurine phosphorothioate oligonucleotides form stable triplexes with the rat α1 (I) collagen gene promoter and inhibit transcription in cultured rat fibroblasts
11. Triplex formation prevents Sp1 binding to the dihydrofolate reductase promoter
12. Detection of covalent triplex within human cells
13. Accessibility of nuclear DNA to triplex-forming oligonucleotides: The integrated HIV-1 provirus as a target
14. Sequence-specific targeting and covalent modification of human genomic DNA
15. Triple helix-forming oligonucleotides target psoralen adducts to specific chromosomal sequences in human cells
16. Nucleosome core particles inhibit DNA triple helix formation
17. Cationic oligonucleotides can mediate specific inhibition of gene expression in Xenopus oocytes
18. Triple helix DNA alters nucleosomal histone-DNA interactions and acts as a nucleosome barrier
19. Site-specific oligonucleotide binding represses transcription of the human c-myc gene in vitro
20. Evidence that a triplex-forming oligodeoxyribonucleotide binds to the c-myc promoter in HeLa cells, thereby reducing c-myc mRNA levels
21. Inhibition of gene expression by triple helix-directed DNA cross-linking at specific sites
22. Inhibition of transcription of the human c-myc protooncogene by intermolecular triplex
23. Triple helix formation inhibits transcription elongation in vitro
24. Inhibition of RNA polymeras eII transcription in human cells by synthetic DNA-binding ligands
25. Inhibition of aromatase expression by a psoralen-linked triplex-forming oligonucleotide targeted to a coding sequence
26. Regulation of gene expression by small molecules
27. Relief of triple-helix-mediated promoter inhibition by elongating RNA polymerases
28. DNA damage-dependent transcriptional arrest and termination of RNA polymerase II elongation complexes in DNA template containing HIV-1 promoter
29. Inhibition of transcription elongation in the HER-2/neu coding sequence by triplex-directed covalent modification of the template strand
30. Stable triple helices formed by oligonucleotide N3′→P5′ phosphoramidates inhibit transcription elongation
31. Efficient inhibition of transcription elongation in vitro by oligonucleotide phosphoramidates targeted to proviral HIV DNA
32. Targeted inhibition of transcription elongation in cells mediated by triplex-forming oligonucleotides
33. Transcription inhibition induced by modified triple helix-forming oligonucleotides: A quantitative assay for evaluation in cells
34. Evidence for (PNA)2/DNA triplex structure upon binding of PNA to dsDNA by strand displacement
35. In vitro transcription and translation inhibition by anti-promyelocytic leukemia (PML)/retinoic acid receptor α and anti-PML peptide nucleic acid
36. Transcription-mediated binding of peptide nucleic acid (PNA) to double-stranded DNA: Sequence-specific suicide transcription
37. Pax5 (BSAP) regulates the murine immunoglobulin 3′ α enhancer by suppressing binding of NF-α P, a protein that controls heavy chain transcription
38. Gene activation by triplex-forming oligonucleotide coupled to the activating domain of protein VP16
39. Peptide nucleic acid. DNA strand displacement loops as artificial transcription promoters
40. Peptide nucleic acid (PNA) binding-mediated induction of human γ-globin gene expression
41. Targeted mutagenesis in mammalian cells mediated by intracellular triple helix formation
42. Mutagenesis in mammalian cells induced by triple helix formation and transcription-coupled repair
43. Recombination induced by triple-helix-targeted DNA damage in mammalian cells
44. Chromosomal mutations induced by triplex-forming oligonucleotides in mammalian cells
45. Specific mutations induced by triplex-forming oligonucleotides in mice
46. Peptide nucleic acid-targeted mutagenesis of a chromosomal gene in mouse cells
47. Targeted mutagenesis of DNA using triple helix-forming oligonucleotides linked to psoralen
48. Targeted gene knockout mediated by triple helix forming oligonucleotides
49. Unambiguous demonstration of triple-helix-directed gene modification
50. Design of a triple-helix-specific cleaving reagent
51. High-frequency intrachromosomal gene conversion induced by triplex-forming oligonucleotides microinjected into mouse cells
52. Triple-helix formation induces recombination in mammalian cells via a nucleotide excision repair-dependent pathway
53. Interstrand cross-links induce DNA synthesis in damaged and undamaged plasmids in mammalian cell extracts
54. Targeted correction of an episomal gene in mammalian cells by a short DNA fragment tethered to a triplex-forming oligonucleotide
55. Homologous recombination involving small single-stranded oligonucleotides in human cells
56. Targeted replacement of normal and mutant CFTR sequences in human airway epithelial cells using DNA fragments
57. Strand invasion of supercoiled DNA by oligonucleotides with a triplex guide sequence
58. Repairing the sickle cell mutation. I. Specific covalent binding of a photoreactive third strand to the mutated base pair
59. Triplex-induced recombination in human cell-free extracts. Dependence on xpa and hsrad51
60. Second structural motif for recognition of DNA by oligonucleotide-directed triple-helix formation
61. Formation of the triple-stranded polynucleotide helix, poly(A.A.U)
62. Overcoming potassium-mediated triplex inhibition
63. Monovalent cation effects on intermolecular purine-purine-pyrimidine triple-helix formation
64. High-affinity triple helix formation by synthetic oligonucleotides at a site within a selectable mammalian gene
65. Incorporation of 2′-deoxy-6-thioguanosine into G-rich oligodeoxyribonucleotides inhibits G-tetrad formation and facilitates triplex formation
66. An anti-parallel triple helix motif with oligodeoxynucleotides containing 2′-deoxyguanosine and 7-deaza-2′-deoxyxanthosine
67. Potassium-resistant triple helix formation and improved intracellular gene targeting by oligodeoxyribonucleotides containing 7-deazaxanthine
68. Positively charged oligonucleotides overcome potassium-mediated inhibition of triplex DNA formation
69. Understanding oligonucleotide-mediated inhibition of gene expression in Xenopus laevis oocytes
70. Sequence-specific cleavage of double helical DNA by triple helix formation
71. Triple helix formation by oligonucleotides on DNA extended to the physiological range
72. Triplex formation by oligonucleotides containing 5-(1-propynyl)-2′-deoxyuridine: Decreased magnesium dependence and improved intracellular gene targeting
73. Recognition of a guanine-cytosine base pair by 8-oxoadenine
74. 7,8-Dihydro-8-oxoadenine as a replacement for cytosine in the third strand of triple helices. Triplex formation without hypochromicity
75. Sequence composition effects on the stabilities of triple helix formation by oligonucleotides containing N7-deoxyguanosine
76. Triple helix formation with oligodeoxyribonucleotides containing 8-oxo-2′-deoxyadenosine and 2′-modified nucleoside derivatives
77. DNA-triplex stabilizing properties of 8-aminoguanine
78. Triple helix formation and the antigene strategy for sequence-specific control of gene expression
79. Pyrimidine morpholino oligonucleotides form a stable triple helix in the absence of magnesium ions
80. Oligonucleotide analogues: An overview
81. Stable triple helices are formed upon binding of RNA oligonucleotides and their 2′-O-methyl derivatives to double-helical DNA
82. Targeted gene knockout by 2′-O-aminoethyl triplex forming oligonucleotides
83. Sequence-selective recognition of DNA by strand displacement with a thymine-substituted polyamide
84. Double duplex invasion by peptide nucleic acid: A general principle for sequence-specific targeting of double-stranded DNA
85. Progress in developing PNA as a gene-targeted drug
86. Peptide nucleic acid: A versatile tool in genetic diagnostics and molecular biology
87. Binding of an antitumor drug to DNA. Netropsin and C-G-C-G-A-A-T-T-BrC-G-C-G
88. Cyclic polyamides for recognition in the minor groove of DNA
89. Sequence-specific DNA recognition by polyamides
90. Recognition of the four Watson-Crick base pairs in the DNA minor groove by synthetic ligands
91. Anti-repression of RNA polymerase II transcription by pyrrole-imidazole polyamides
92. Activation of gene expression by small molecule transcription factors
93. Differential regulation of gene expression in vivo by triple helix-forming oligonucleotides as detected by a reporter enzyme
94. Temporary ex vivo inhibition of the expression of the human oncogene HER2 (NEU) by a triple helix-forming oligonucleotide
95. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: Polyethylenimine
96. DNA triplex formation selectively inhibits granulocyte-macrophage colony-stimulating factor gene expression in human T cells
97. The third helix of the Antennapedia homeodomain translocates through biological membranes
98. Transport of oligonucleotides across natural and model membranes
99. Improved intracellular delivery of oligonucleotides by square wave electroporation
100. In vivo expression of single-stranded DNA in mammalian cells with DNA enzyme sequences targeted to C-raf